AKT1 and glioblastoma: Inhibition of BCAA metabolism promotes glioblastoma cell apoptosis by disrupting mitochondrial dynamics mediated by mitofusin 2 (Mfn2) and inhibiting the PI3K/AKT/mTOR pathway, making it a potential novel therapeutic target for treating glioblastoma (Lu et al., 2024b).